-
aTyr Pharma to Participate in ROTH Capital Partners Webinar on COVID-19 Therapeutics in Development on October 28th
-
aTyr Pharma to Participate in October Virtual Investor Events
-
aTyr Pharma Announces Exercise and Closing of Over-Allotment Option in Public Offering
-
Roth Capital Starts aTyr Pharma (LIFE) at Buy
-
aTyr Pharma (LIFE) Prices 4.235M Share Common Offering at $4.25/Sh
-
aTyr Pharma (LIFE) Prices $18M Underwritten Public Offering of Common Stock at $4.25/Share
-
aTyr Pharma Announces Pricing of $18 million Underwritten Public Offering
-
aTyr Pharma Announces Pricing of $18 million Underwritten Public Offering